Ben Quinney
Hematology & Oncology · Minden, LANPI 1245239342
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,225 and has fallen 98.1% since, to $23 in 2025. That places this record below the midpoint for hematology & oncology clinicians in LA, where the typical reported total is $4,451.
Across 133 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$446
- Johnson & Johnson$351
- Merck$174
- Pharmacyclics LLC, An Abbvie Company$153
- E.r. Squibb & Sons, L.L.C.$133
- Amgen$117
- plus $795 from 27 others
What the payments were for
- Food & beverage$2,04094%
- Education$1286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 31 | $446 |
| Johnson & Johnson | 19 | $351 |
| Merck | 11 | $174 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $153 |
| E.r. Squibb & Sons, L.L.C. | 12 | $133 |
| Amgen | 7 | $117 |
| Coherus Oncology, Inc. | 5 | $85 |
| Daiichi Sankyo Inc. | 4 | $80 |
| AstraZeneca | 5 | $66 |
| Bristol Myers Squibb | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Sanofi | 2 | $45 |
| Pfizer | 3 | $45 |
| Genentech USA, Inc. | 2 | $32 |
| GSK | 1 | $28 |
| Lilly USA, LLC | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Sobi, Inc | 1 | $23 |
| Tesaro, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| AbbVie | 1 | $21 |
| Bayer | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Dova Pharmaceuticals | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
| Incyte Corporation | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Emmaus Medical, Inc. | 1 | $12 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
| Seagen Inc. | 1 | $12 |
| Gilead | 1 | $11 |
How this compares
$2,168 in reported general payments places this provider in the 25th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in Minden
- Manish DhawanMinden$28K
- Hana SafahBaton Rouge$2M
- Pedro BarataNew Orleans$928K
- Maissaa JanbainNew Orleans$862K
- Nakhle SabaBaton Rouge$842K
- Marc MatranaNew Orleans$757K
- Prakash PeddiShreveport$405K
- Sanjay JunejaBaton Rouge$346K
- Lingling duNew Orleans$173K
- Kamran ShahidLake Charles$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.